Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominic Oliver

Showing results (91-100 of 111) with videos related to

Pageof 12
Sort By:
Brain, Behavior, and Immunity|April 9, 2025
Do biological alterations precede the onset of psychosis? A systematic review and meta-analysis of immune, cardiometabolic, prolactin and HPA axis alterations in clinical high-risk for psychosisClaudia Aymerich, Borja Pedruzo, Gonzalo Salazar de Pablo, et al.
Neuroscience and Biobehavioral Reviews|June 4, 2026
The subjective effects of △9-tetrahydrocannabinol: A systematic review and dose-response meta-regressionIsabella Goodwin, Dominic Oliver, Edward Chesney, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 11, 2019
Oxytocin modulates hippocampal perfusion in people at clinical high risk for psychosisCathy Davies, Yannis Paloyelis, Grazia Rutigliano, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 1, 2019
Neurochemical effects of oxytocin in people at clinical high risk for psychosisCathy Davies, Grazia Rutigliano, Andrea De Micheli, et al.
Schizophrenia Bulletin|October 27, 2025
Testing the Transportability of the Psychosis Metabolic Risk Calculator in Canada (Quebec): International External Validation StudySébastien Brodeur, Olivier Corbeil, Laurent Béchard, et al.
Molecular Psychiatry|January 19, 2024
Connectome dysfunction in patients at clinical high risk for psychosis and modulation by oxytocinCathy Davies, Daniel Martins, Ottavia Dipasquale, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 30, 2022
Ethical considerations for precision psychiatry: A roadmap for research and clinical practicePaolo Fusar-Poli, Mirko Manchia, Nikolaos Koutsouleris, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|January 14, 2023
Impact of mental disorders on clinical outcomes of physical diseases: an umbrella review assessing population attributable fraction and generalized impact fractionElena Dragioti, Joaquim Radua, Marco Solmi, et al.
Translational Psychiatry|June 24, 2020
Acute oxytocin effects in inferring others' beliefs and social emotions in people at clinical high risk for psychosisAndré Schmidt, Cathy Davies, Yannis Paloyelis, et al.
The Lancet. Psychiatry|March 30, 2020
Prenatal and perinatal risk and protective factors for psychosis: a systematic review and meta-analysisCathy Davies, Giulia Segre, Andrés Estradé, et al.
Pageof 12

Showing results (91-100 of 111) with videos related to

Sort By:
Pageof 12
Brain, Behavior, and Immunity|April 9, 2025
Do biological alterations precede the onset of psychosis? A systematic review and meta-analysis of immune, cardiometabolic, prolactin and HPA axis alterations in clinical high-risk for psychosisClaudia Aymerich, Borja Pedruzo, Gonzalo Salazar de Pablo, et al.
Neuroscience and Biobehavioral Reviews|June 4, 2026
The subjective effects of △9-tetrahydrocannabinol: A systematic review and dose-response meta-regressionIsabella Goodwin, Dominic Oliver, Edward Chesney, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 11, 2019
Oxytocin modulates hippocampal perfusion in people at clinical high risk for psychosisCathy Davies, Yannis Paloyelis, Grazia Rutigliano, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 1, 2019
Neurochemical effects of oxytocin in people at clinical high risk for psychosisCathy Davies, Grazia Rutigliano, Andrea De Micheli, et al.
Schizophrenia Bulletin|October 27, 2025
Testing the Transportability of the Psychosis Metabolic Risk Calculator in Canada (Quebec): International External Validation StudySébastien Brodeur, Olivier Corbeil, Laurent Béchard, et al.
Molecular Psychiatry|January 19, 2024
Connectome dysfunction in patients at clinical high risk for psychosis and modulation by oxytocinCathy Davies, Daniel Martins, Ottavia Dipasquale, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 30, 2022
Ethical considerations for precision psychiatry: A roadmap for research and clinical practicePaolo Fusar-Poli, Mirko Manchia, Nikolaos Koutsouleris, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|January 14, 2023
Impact of mental disorders on clinical outcomes of physical diseases: an umbrella review assessing population attributable fraction and generalized impact fractionElena Dragioti, Joaquim Radua, Marco Solmi, et al.
Translational Psychiatry|June 24, 2020
Acute oxytocin effects in inferring others' beliefs and social emotions in people at clinical high risk for psychosisAndré Schmidt, Cathy Davies, Yannis Paloyelis, et al.
The Lancet. Psychiatry|March 30, 2020
Prenatal and perinatal risk and protective factors for psychosis: a systematic review and meta-analysisCathy Davies, Giulia Segre, Andrés Estradé, et al.
Pageof 12